Medicover confirmed the ongoing negotiations following reports that KKR aims to purchase the Swedish firm’s 66.9% stake in its Indian subsidiary. The buyout firm is also engaged in discussions with minority shareholders to secure a controlling interest in a network that currently spans 26 hospitals and roughly 6,000 beds. While a non-binding agreement has been reached, Medicover maintains that it is continuing preparations for an initial public offering in India as a contingency.

KKR has aggressively increased its footprint in the Indian medical market, including a recent acquisition of a hospital chain in Kerala. The sector remains a primary target for global investors, fueled by rising incomes and broader health insurance coverage. Rothschild is advising on the sale, while Kotak is representing KKR. Medicover’s Indian unit, which accounts for over half of the group's global hospital capacity, reported revenue of $234.6 million in 2025.